The autoRIC™ Device - CE Mark approved in EU
The autoRIC™ Device provides a non-invasive, safe and accurate device to automate RIC. Placed around the arm, CellAegis’ autoRIC™ Device for the first time allows simple, consistent, reliable and cost‐effective automation of RIC at the point of care. The autoRIC™ Device is highly portable and time‐efficient, delivering four cycles of simple‐to-administer treatment in less than 40 minutes. The device is compatible with current standard‐of‐care treatments.
CellAegis’ autoRIC™ Device has potential applications across the spectrum of care: in acute care settings, including treatment of patients in the ambulance or emergency room, prior to surgery, and in the home for chronic treatment.
The autoRIC™ Device is the only patented device with CE Mark certification in Europe and a Health Canada Class III License Approval, that can automate the process of RIC. The autoRIC™ Device is not for sale or commercial distribution in the US.
For additional information on CellAegis’ autoRIC™ Device, pleasecontact us.
